Robert E. Rangno
YOU?
Author Swipe
View article: An Easier Approach to Estimating Risk of Coronary Heart Disease and Stroke
An Easier Approach to Estimating Risk of Coronary Heart Disease and Stroke Open
View article: Primary prevention of heart disease and stroke
Primary prevention of heart disease and stroke Open
View article: Nonspecific arousal with noloxone.
Nonspecific arousal with noloxone. Open
The use of naloxone, the first narcotic antagonist devoid of agonist properties, has become the standard way of treating narcotic-induced coma and respiratory depression. This report concerns a patient in whom a narcotic effect was unlikel…
View article: Antihypertensive efficacy of propranolol given twice daily.
Antihypertensive efficacy of propranolol given twice daily. Open
The therapeutic efficacy of propranolol in four and two daily doses was compared in 63 treated hypertensive patients in a multicentre trial. After 3 months of a stable diastolic blood pressure while receiving propranolol four times a day t…
View article: Mechanism of propranolol withdrawal phenomena.
Mechanism of propranolol withdrawal phenomena. Open
Nine patients on chronic treatment with propranolol for essential hypertension for 3 months or longer were studied after abrupt discontinuation of the drug. Each patient demonstrated transient supersensitivity to the chronotropic effects o…
View article: Effects of a False Neurotransmitter, p-Hydroxynorephedrine, on the Function of Adrenergic Neurons in Hypertensive Patients
Effects of a False Neurotransmitter, p-Hydroxynorephedrine, on the Function of Adrenergic Neurons in Hypertensive Patients Open
Previous studies have shown that amphetamine and p-hydroxyamphetamine impair adrenergic transmission, and it has been suggested that this effect is mediated by an active metabolite, p-hydroxynorephedrine (PHN). Studies in experimental anim…
View article: Subject Index Vol. 8, 1972
Subject Index Vol. 8, 1972 Open